Growing community of inventors

South San Francisco, CA, United States of America

Michael Asensio

Average Co-Inventor Count = 8.20

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Michael AsensioDavid Scott Johnson (5 patents)Michael AsensioAdam Shultz Adler (5 patents)Michael AsensioYoong Wearn Lim (5 patents)Michael AsensioRena Aviva Mizrahi (4 patents)Michael AsensioKacy Stadtmiller (3 patents)Michael AsensioSheila Keating (3 patents)Michael AsensioAngelica V Medina-Cucurella (3 patents)Michael AsensioAriel Niedecken (3 patents)Michael AsensioEmily Benzie (3 patents)Michael AsensioMatthew James Spindler (1 patent)Michael AsensioEllen Wagner (1 patent)Michael AsensioAyla Lynn Nelson (1 patent)Michael AsensioErica Lyn Stone (1 patent)Michael AsensioAviva Mizrahi Rena (1 patent)Michael AsensioWearn Lim Yoong (1 patent)Michael AsensioScott Johnson David (1 patent)Michael AsensioLyn Stone Erica (1 patent)Michael AsensioMichael Asensio (5 patents)David Scott JohnsonDavid Scott Johnson (27 patents)Adam Shultz AdlerAdam Shultz Adler (19 patents)Yoong Wearn LimYoong Wearn Lim (6 patents)Rena Aviva MizrahiRena Aviva Mizrahi (17 patents)Kacy StadtmillerKacy Stadtmiller (3 patents)Sheila KeatingSheila Keating (3 patents)Angelica V Medina-CucurellaAngelica V Medina-Cucurella (3 patents)Ariel NiedeckenAriel Niedecken (3 patents)Emily BenzieEmily Benzie (3 patents)Matthew James SpindlerMatthew James Spindler (7 patents)Ellen WagnerEllen Wagner (5 patents)Ayla Lynn NelsonAyla Lynn Nelson (1 patent)Erica Lyn StoneErica Lyn Stone (1 patent)Aviva Mizrahi RenaAviva Mizrahi Rena (1 patent)Wearn Lim YoongWearn Lim Yoong (1 patent)Scott Johnson DavidScott Johnson David (1 patent)Lyn Stone EricaLyn Stone Erica (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Gigagen, Inc. (4 from 21 patents)

2. Gigamune, Inc. (1 from 4 patents)


5 patents:

1. 12421311 - Anti-CTLA-4 binding proteins and methods of use thereof

2. 12404607 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof

3. 11718660 - Recombinant polyclonal proteins targeting Zika and methods of use thereof

4. 11685779 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof

5. 11421220 - Engineered cells expressing anti-viral T cell receptors and methods of use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/17/2025
Loading…